Skip to content

Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort)

Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort)

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07795255
Enrollment
1740
Registered
2026-08-31
Start date
2026-11-01
Completion date
2031-09-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder (Urothelial, Transitional Cell) Cancer, Hematuria

Keywords

Cystoscopy, Bladder Cancer, Hematuria, Microhematuria

Brief summary

The goal of this study is to learn methods doctors can use to help improve the cystoscopy experience. Specifically, this study will determine if listening to music, and the amount of time Lidocaine (a numbing medication) is allowed to rest in your urethra before beginning the cystoscopy procedure, will improve the cystoscopy experience.

Detailed description

For patients undergoing cystoscopy who choose or do not choose to watch the procedure on a screen: Does long vs. short dwell-time lidocaine, and music vs. no music, more effectively reduce pain and anxiety and improve satisfaction and adherence to clinician recommendations for follow-up.

Interventions

Music playlists include Jazz, New Age, and Classical. Participants randomized to listening to music will chose to listen to one of the three playlists provided. Headphones with a single-use cover will be placed over the ears prior to the administration of numbing medication, and prior to the start of the cystoscopy procedure.

DRUGDwell time 5-10 minutes

Numbing medication dwell time, 5-10 minutes.

DRUGDwell Time more than 10 minutes

Numbing medication dwell time, \>10 minutes.

Sponsors

Florian Schroeck
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

2 x 2 factorial design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing office-based cystoscopy for bladder cancer diagnosis, surveillance, or evaluation of anatomic abnormalities.

Exclusion criteria

* Allergy to or intolerance of lidocaine. * Intolerance of all offered music genre playlists (Jazz, Classical, New Age), such that no acceptable music option exists. * Known pregnancy or lactation (routine pregnancy testing is not required)

Design outcomes

Primary

MeasureTime frameDescription
Pain levelAssessed immediately after each cystoscopy procedure.Visual Analogue Scale. Scale is 0-10; higher number indicates higher level of pain

Secondary

MeasureTime frameDescription
Pain intensityAssessed immediately after each cystoscopy procedure.PROMIS Pain Intensity Scale v2.0 - Pain Intensity 3a. Scale is 1-5; higher number indicates higher level of pain.
Level of emotional distress and anxietyAssessed immediately after each cystoscopy procedure.PROMIS Emotional Distress-Anxiety Short Form 4a. Scale is 1-5; higher number indicates higher level of distress-anxiety.
Patient SatisfactionAssessed immediately after each cystoscopy procedure;Client Satisfaction Questionnaire (CSQ-3). Scale is 1-4; higher number indicates higher level of satisfaction.

Countries

United States

Contacts

CONTACTLaura L Jensen, MPH
Laura.Jensen@va.gov802-295-9363
CONTACTFlorian R Schroeck, MD, MS
Florian.Schroeck@va.gov802-295-9363
PRINCIPAL_INVESTIGATORFlorian R Schroeck, MD, MS

White River Junction Veterans Healthcare System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026